Pharma Journalist -

Kazia Therapeutics Limited announced plans to hold a follow-up Type C meeting with the U.S. Food and Drug Administration (FDA) to discuss new overall survival (OS) findings from…
Read More...

Novartis announced that it has successfully completed the acquisition of Tourmaline Bio, Inc., making the biotechnology company an indirect wholly owned subsidiary of Novartis.…
Read More...

Guardant Health, a leader in precision oncology, has announced a strategic partnership with Zephyr AI, a precision medicine company specializing in artificial intelligence, to…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of WINREVAIR™ (sotatercept-csrk) for the…
Read More...

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic treatments for rare bleeding and thrombotic disorders, has raised $157 million in a heavily…
Read More...

Lifecore Biomedical, Inc. and PolyPeptide Laboratories, Inc. have announced a collaboration to offer fully integrated development and manufacturing services for peptide-based…
Read More...

Tokyo - February 26-27, 2026 - The Targeted Therapies Partnering & Licensing Summit Asia is set to unite industry leaders, investors, and biopharma innovators across the region to…
Read More...

GSK plc has entered into an agreement with Syndivia, a private biotechnology company specializing in next-generation antibody-drug conjugates (ADCs), granting GSK exclusive worldwide…
Read More...

Eli Lilly and Company announced it will acquire Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage biotechnology company pioneering intravitreal gene therapies for eye…
Read More...

Alkermes plc has announced plans to acquire Avadel Pharmaceuticals plc in a $2.1 billion all-cash deal, marking a major strategic move to expand its presence into the fast-growing sleep…
Read More...